Item Type: | Review |
---|---|
Title: | Biomarkers in acute kidney injury - pathophysiological basis and clinical performance |
Creators Name: | Schrezenmeier, E.V., Barasch, J., Budde, K., Westhoff, T. and Schmidt-Ott, K.M. |
Abstract: | Various biomarkers of acute kidney injury (AKI) have been discovered and characterized in the recent past. These molecules can be detected in urine or blood and signify structural damage to the kidney. Clinically, they are proposed as adjunct diagnostics to serum creatinine and urinary output to improve the early detection, differential diagnosis and prognostic assessment of AKI. The most obvious requirements for a biomarker include its reflection of the underlying pathophysiology of the disease. Hence, a biomarker of AKI should derive from the injured kidney and reflect a molecular process intimately connected with tissue injury. Here, we provide an overview of the basic pathophysiology, the cellular sources and the clinical performance of the most important currently proposed biomarkers of acute kidney injury: neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), liver-type fatty acid-binding protein (L-FABP), interleukin 18 (IL-18), insulin-like growth factor binding protein 7 (IGFBP7), tissue inhibitor of metalloproteinase 2 (TIMP-2), and calprotectin (S100A8/9). We also acknowledge each biomarker's advantages and disadvantages as well as important knowledge gaps and perspectives for future studies. |
Keywords: | Acute Kidney Injury, Biomarkers, Neutrophil Gelatinase-associated Lipocalin (NGAL), Kidney Injury Molecule 1 (KIM-1), Liver-type Fatty Acid-binding Protein (L-FABP), Interleukin 18 (IL-18), Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) and IGF-binding Protein 7 (IGFBP7), Calprotectin |
Source: | Acta Physiologica |
ISSN: | 1748-1708 |
Publisher: | Wiley |
Volume: | 219 |
Number: | 3 |
Page Range: | 554-572 |
Date: | March 2017 |
Additional Information: | Copyright © 2016 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd. |
Official Publication: | https://doi.org/10.1111/apha.12764 |
External Fulltext: | View full text on PubMed Central |
PubMed: | View item in PubMed |
Repository Staff Only: item control page